MyAverix Finance
NS · Pharmaceuticals
Nectar Lifesciences Ltd (NECLIFE)
Pharmaceuticals & Biotechnology
Nectar Lifesciences Ltd (NECLIFE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.25B, P/E ratio is -0.77, net margin is -1,053.0%, dividend yield is 0.43%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NECLIFE
Nectar Lifesciences Ltd (NECLIFE) — FAQ
What is Nectar Lifesciences Ltd's market cap?
Nectar Lifesciences Ltd (NECLIFE) has a reported market cap of $2.25B (data as of 2026-07-10).
What is NECLIFE's P/E ratio?
The price-to-earnings (P/E) ratio for Nectar Lifesciences Ltd (NECLIFE) is -0.77 (data as of 2026-07-10).
Does Nectar Lifesciences Ltd pay a dividend?
Nectar Lifesciences Ltd (NECLIFE) shows a reported dividend yield of 0.43%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Nectar Lifesciences Ltd in?
Nectar Lifesciences Ltd (NECLIFE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is NECLIFE listed on?
NECLIFE is listed on NS.
What is Nectar Lifesciences Ltd's net margin?
Nectar Lifesciences Ltd (NECLIFE) reports a net margin of -1,053.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.